SCHEMBL8634299

SCHEMBL8634299

C[N]C(Cc1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.46
SLC6A2 P23975 4/20 0.45
TAAR1 Q96RJ0 4/20 0.45
SLC6A4 P31645 3/20 0.45
SLC6A3 Q01959 3/20 0.45
MAOA P21397 1/20 0.45
CYP2A6 P11509 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
EPHX1 P07099 2/20 0.43
SLC18A2 Q05940 1/20 0.42
CYP2D6 P10635 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
HTR1A P08908 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
DRD2 P14416 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5442166 0.82 SLC6A2 (0.47) SIGMAR1SLC6A2TAAR1SLC6A4SLC6A3
SCHEMBL5442165 0.82 SLC6A2 (0.47) SIGMAR1SLC6A2TAAR1SLC6A4SLC6A3
SCHEMBL16213431 0.78 EPHX1 (0.46) SIGMAR1SLC6A2TAAR1SLC6A4SLC6A3
SCHEMBL15939446 0.78 SLC6A2 (0.44) SIGMAR1SLC6A2TAAR1SLC6A4SLC6A3
SCHEMBL14304846 0.78 EPHX1 (0.46) SIGMAR1SLC6A2TAAR1SLC6A4SLC6A3
SCHEMBL2404477 0.77 MIF (0.59) TAAR1HTR2AHRH1MIFTRPA1
SCHEMBL919175 0.77 MIF (0.59) TAAR1HTR2AHRH1MIFTRPA1
SCHEMBL4199092 0.76 TRPA1 (0.45) TAAR1HTR2AHRH1MIFTRPA1
SCHEMBL17399250 0.75 EPHX1 (0.45) SIGMAR1SLC6A2TAAR1SLC6A4SLC6A3
SCHEMBL919486 0.74 MIF (0.46) SIGMAR1TAAR1HTR2AHRH1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763053-A4 STEROID DERIVATIVES FOR TREATMENT OF 5 ALPHA REDUCTASE SMITHKLINE BEECHAM CORP (US) 1998-09-09 EP disclosed
EP-0763053-A1 STEROID DERIVATIVES FOR TREATMENT OF 5 ALPHA REDUCTASE SMITHKLINE BEECHAM CORPORATION (US) 1997-03-19 EP disclosed
WO-1995033761-A1 STEROID DERIVATIVES FOR TREATMENT OF 5 ALPHA REDUCTASE SMITHKLINE BEECHAM CORPORATION (US) 1995-12-14 WO disclosed